OIA
VRTX icon

OneDigital Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

OneDigital Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$10K – 719
2020
Q2 		$10K Buy
+200
New +$54.2K ﹤0.01% 629

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OneDigital Investment Advisors's VRTX Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q2 2026, selling an estimated $1.12M and leaving 1,684 shares worth $836K. The position accounts for 0.01% of the portfolio, ranked #811.

OneDigital Investment Advisors first reported a position in VRTX in Q2 2017 and has held it in 27 quarters since. The position peaked at $2.9M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • OneDigital Investment Advisors held 1,684 shares of Vertex Pharmaceuticals worth $836K as of Q2 2026.
  • OneDigital Investment Advisors sold 2,528 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Vertex Pharmaceuticals made up 0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #811 holding.
  • OneDigital Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 27 quarters since.
  • OneDigital Investment Advisors's Vertex Pharmaceuticals position peaked at $2.9M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.